176 related articles for article (PubMed ID: 9328445)
1. New strains of inbred SENCAR mice with increased susceptibility to induction of papillomas and squamous cell carcinomas in skin.
Hennings H; Lowry DT; Yuspa SH; Mock B; Potter M
Mol Carcinog; 1997 Sep; 20(1):143-50. PubMed ID: 9328445
[TBL] [Abstract][Full Text] [Related]
2. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin.
Hennings H; Glick AB; Lowry DT; Krsmanovic LS; Sly LM; Yuspa SH
Carcinogenesis; 1993 Nov; 14(11):2353-8. PubMed ID: 8242866
[TBL] [Abstract][Full Text] [Related]
3. Comparison of two-stage epidermal carcinogenesis initiated by 7,12-dimethylbenz(a)anthracene or N-methyl-N'-nitro-N-nitrosoguanidine in newborn and adult SENCAR and BALB/c mice.
Hennings H; Devor D; Wenk ML; Slaga TJ; Former B; Colburn NH; Bowden GT; Elgjo K; Yuspa SH
Cancer Res; 1981 Mar; 41(3):773-9. PubMed ID: 6780187
[TBL] [Abstract][Full Text] [Related]
4. Dissociation of sensitivities to tumor promotion and progression in outbred and inbred SENCAR mice.
Gimenez-Conti IB; Bianchi AB; Fischer SM; Reiners JJ; Conti CJ; Slaga TJ
Cancer Res; 1992 Jun; 52(12):3432-5. PubMed ID: 1375869
[TBL] [Abstract][Full Text] [Related]
5. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
[TBL] [Abstract][Full Text] [Related]
6. Malignant conversion and metastasis of mouse skin tumors: a comparison of SENCAR and CD-1 mice.
Hennings H; Spangler EF; Shores R; Mitchell P; Devor D; Shamsuddin AK; Elgjo KM; Yuspa SH
Environ Health Perspect; 1986 Sep; 68():69-74. PubMed ID: 3780634
[TBL] [Abstract][Full Text] [Related]
7. Analysis of two inbred strains of mice derived from the SENCAR stock with different susceptibility to skin tumor progression.
Stern MC; Gimenez-Conti IB; Budunova I; Coghlan L; Fischer SM; DiGiovanni J; Slaga TJ; Conti CJ
Carcinogenesis; 1998 Jan; 19(1):125-32. PubMed ID: 9472703
[TBL] [Abstract][Full Text] [Related]
8. Methylation of the O6-methylguanine-DNA methyltransferase promoter suppresses expression in mouse skin tumors and varies with the tumor induction protocol.
Abdel-Fattah R; Glick A; Rehman I; Maiberger P; Hennings H
Int J Cancer; 2006 Feb; 118(3):527-31. PubMed ID: 16094607
[TBL] [Abstract][Full Text] [Related]
9. Protection against induction of mouse skin papillomas with low and high risk of conversion to malignancy by green tea polyphenols.
Katiyar SK; Mohan RR; Agarwal R; Mukhtar H
Carcinogenesis; 1997 Mar; 18(3):497-502. PubMed ID: 9067548
[TBL] [Abstract][Full Text] [Related]
10. Further characterization of skin tumor promotion and progression by mezerein in SENCAR mice.
Ewing MW; Conti CJ; Phillips JL; Slaga TJ; DiGiovanni J
J Natl Cancer Inst; 1989 May; 81(9):676-82. PubMed ID: 2496233
[TBL] [Abstract][Full Text] [Related]
11. Further studies on the influence of initiation dose on papilloma growth and progression during two-stage carcinogenesis in SENCAR mice.
DiGiovanni J; Walker SE; Aldaz CM; Slaga TJ; Conti CJ
Carcinogenesis; 1993 Sep; 14(9):1831-6. PubMed ID: 8403206
[TBL] [Abstract][Full Text] [Related]
12. Frequent codon 12 Ki-ras mutations in mouse skin tumors initiated by N-methyl-N'-nitro-N-nitrosoguanidine and promoted by mezerein.
Rehman I; Lowry DT; Adams C; Abdel-Fattah R; Holly A; Yuspa SH; Hennings H
Mol Carcinog; 2000 Apr; 27(4):298-307. PubMed ID: 10747294
[TBL] [Abstract][Full Text] [Related]
13. Vitamin E is a complete tumor promoter in mouse skin.
Mitchel RE; McCann R
Carcinogenesis; 1993 Apr; 14(4):659-62. PubMed ID: 8472330
[TBL] [Abstract][Full Text] [Related]
14. Differential carcinogenic effects of intraperitoneal initiation with 7,12-dimethylbenz(a)anthracene or urethane and topical promotion with 12-O-tetradecanoylphorbol-13-acetate in skin and internal tissues of female SENCAR and BALB/c mice.
Ward JM; Rehm S; Devor D; Hennings H; Wenk ML
Environ Health Perspect; 1986 Sep; 68():61-8. PubMed ID: 3096710
[TBL] [Abstract][Full Text] [Related]
15. SENCAR mouse skin tumorigenesis model versus other strains and stocks of mice.
Slaga TJ
Environ Health Perspect; 1986 Sep; 68():27-32. PubMed ID: 3096709
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of 129/SvEv mice in two-stage carcinogenesis protocols to 12-O-tetradecanoylphorbol-13-acetate promotion.
Reiners JJ; Singh KP
Carcinogenesis; 1997 Mar; 18(3):593-7. PubMed ID: 9067561
[TBL] [Abstract][Full Text] [Related]
17. Development and initial characterization of several new inbred strains of SENCAR mice for studies of multistage skin carcinogenesis.
Coghlan LG; Gimenez-Conti I; Kleiner HE; Fischer SM; Rundhaug JE; Conti CJ; Slaga TJ; DiGiovanni J
Carcinogenesis; 2000 Apr; 21(4):641-6. PubMed ID: 10753198
[TBL] [Abstract][Full Text] [Related]
18. High dietary retinoic acid inhibits tumor promotion and malignant conversion in a two-stage skin carcinogenesis protocol using 7,12-dimethylbenz[a]anthracene as the initiator and mezerein as the tumor promoter in female SENCAR mice.
Chen LC; Tarone R; Huynh M; De Luca LM
Cancer Lett; 1995 Aug; 95(1-2):113-8. PubMed ID: 7656218
[TBL] [Abstract][Full Text] [Related]
19. Induction of terminal differentiation-resistant epidermal cells in mouse skin and in papillomas by different initiators during two-stage carcinogenesis.
Miller DR; Viaje A; Rotstein J; Aldaz CM; Conti CJ; Slaga TJ
Cancer Res; 1989 Jan; 49(2):410-4. PubMed ID: 2491955
[TBL] [Abstract][Full Text] [Related]
20. Malignant conversion, the first stage in progression, is distinct from phorbol ester promotion in mouse skin.
Hennings H
Basic Life Sci; 1991; 57():31-9; discussion 39-42. PubMed ID: 1814291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]